- Home
- SYRE vs AC Comparison
SYRE vs AC Comparison
Compare SYRE & AC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- AC
- Stock Information
- Founded
- SYRE 2013
- AC 1976
- Country
- SYRE United States
- AC United States
- Employees
- SYRE N/A
- AC N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- AC Investment Bankers/Brokers/Service
- Sector
- SYRE Health Care
- AC Finance
- Exchange
- SYRE Nasdaq
- AC Nasdaq
- Market Cap
- SYRE 897.9M
- AC 809.6M
- IPO Year
- SYRE 2016
- AC N/A
- Fundamental
- Price
- SYRE $12.67
- AC $34.06
- Analyst Decision
- SYRE Buy
- AC
- Analyst Count
- SYRE 8
- AC 0
- Target Price
- SYRE $50.00
- AC N/A
- AVG Volume (30 Days)
- SYRE 899.5K
- AC 7.1K
- Earning Date
- SYRE 05-08-2025
- AC 05-08-2025
- Dividend Yield
- SYRE N/A
- AC 6.43%
- EPS Growth
- SYRE N/A
- AC 20.73
- EPS
- SYRE N/A
- AC 2.08
- Revenue
- SYRE N/A
- AC $13,175,000.00
- Revenue This Year
- SYRE N/A
- AC N/A
- Revenue Next Year
- SYRE N/A
- AC N/A
- P/E Ratio
- SYRE N/A
- AC $16.40
- Revenue Growth
- SYRE N/A
- AC 3.88
- 52 Week Low
- SYRE $10.91
- AC $28.58
- 52 Week High
- SYRE $40.49
- AC $43.85
- Technical
- Relative Strength Index (RSI)
- SYRE 36.18
- AC 42.25
- Support Level
- SYRE $12.04
- AC $32.09
- Resistance Level
- SYRE $13.29
- AC $36.00
- Average True Range (ATR)
- SYRE 1.27
- AC 1.65
- MACD
- SYRE 0.01
- AC -0.08
- Stochastic Oscillator
- SYRE 26.02
- AC 48.81
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
About AC Associated Capital Group Inc.
Associated Capital Group Inc is a diversified global financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.